Michael Howe, CEO, Verify Brand03.07.17
November 2017 is rapidly approaching and with it, the deadlines for the Drug Supply Chain Security Act (DSCSA). As pharmaceutical contract manufacturing organizations (CMOs) and re-packagers and third-party logistics (3PL) providers check the final boxes before implementing serialization, there are a number of considerations to address during vendor selection.
Each company is at a unique place in this process. Some have already implemented serialization while others are still struggling to understand what to look for in a partner or platform. With a priority on fast implementation and compliance, it’s important not to lose sight of other factors critical to long-term success, namely total cost of ownership and value to the business.
Fast-turn implementation
If you fall in the category of “still deciding,” one of the first questions you need to ask your serialization partner is “how long will this take?” Depending on your existing systems, serialization isn’t just one project—it’s a series of changes that include evaluating partner systems and integration p
Each company is at a unique place in this process. Some have already implemented serialization while others are still struggling to understand what to look for in a partner or platform. With a priority on fast implementation and compliance, it’s important not to lose sight of other factors critical to long-term success, namely total cost of ownership and value to the business.
Fast-turn implementation
If you fall in the category of “still deciding,” one of the first questions you need to ask your serialization partner is “how long will this take?” Depending on your existing systems, serialization isn’t just one project—it’s a series of changes that include evaluating partner systems and integration p
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
